[Yanzhou Coal Mining Company Limited Date June 2, 2015 By Zhang Baocai Director and Company Secretary For Main Board and GEM listed issuers Monthly Return of Equity Issuer on Movements in Securities]
[NQ Mobile Inc. Appoints Mr. Roland Wu as Chief Financial Officer BEIJING and DALLAS, June 1, 2015 /PRNewswire/ NQ Mobile Inc. (NQ Mobile or the Company) (NYSE: NQ), a leading global provider of mobile Internet services, today announced the appointment of Mr. Roland Wu as its chief financial officer in addition to his role as director, effective as of] [Form 6-K NQ Mobile Inc. No. 4 Building 11 Heping Li East Street Dongcheng District Beijing 100013 The Peoples Republic of China x ¨ Form 20-F ¨ ¨ NQ Mobile Inc. Zemin Xu Chief Executive Officer 6-K 1 d935862d6k.htm FORM 6-K]
[INVESTOR RELATIONS: John Merriwether, 866-248-3872 InvestorRelations@amctheatres.com MEDIA CONTACTS: Ryan Noonan, (913) 213-2183 rnoonan@amctheatres.com AMC ENTERTAINMENT INC. ANNOUNCES SENIOR SUBORDINATED NOTES OFFERING Leawood, Kansas The Company intends to use the net proceeds from this private offering to pay the consideration for the tender offer to purchase all of the Companys outstanding $600.0 million aggregate principal amount of 9.75% Senior Subordinated Notes] [Summary Historical Financial and Operating Data The following summary historical financial and operating data set forth our historical financial and operating data for (i) the twelve months ended March 31, 2015, (ii) the three months ended March 31, 2015, (iii) the three months ended March 31, 2014, (iv) the twelve months ended December 31, 2014, (v) the twelve months ended] [Item 7.01 Regulation FD Disclosure]
[INVESTOR RELATIONS: John Merriwether, 866-248-3872 InvestorRelations@amctheatres.com MEDIA CONTACTS: Ryan Noonan, (913) 213-2183 rnoonan@amctheatres.com AMC ENTERTAINMENT INC. ANNOUNCES SENIOR SUBORDINATED NOTES OFFERING Leawood, Kansas The Company intends to use the net proceeds from this private offering to pay the consideration for the tender offer to purchase all of the Companys outstanding $600.0 million aggregate principal amount of 9.75% Senior Subordinated Notes] [Summary Historical Financial and Operating Data The following summary historical financial and operating data set forth our historical financial and operating data for (i) the twelve months ended March 31, 2015, (ii) the three months ended March 31, 2015, (iii) the three months ended March 31, 2014, (iv) the twelve months ended December 31, 2014, (v) the twelve months ended] [Item 7.01 Regulation FD Disclosure]
[China Cord Blood Corporations Special Committee Appoints As previously announced, the Companys board of directors formed the Special Committee to review and evaluate the April 27, 2015 non-binding proposal from Golden Meditech Holdings Limited (Golden Meditech) to acquire all of the outstanding ordinary shares of the Company not already directly or indirectly owned by Golden Meditech in a going private] [FORM 6-K Commission Filing Number: 001-34541 CHINA CORD BLOOD CORPORATION 48th Floor, Bank of China Tower 1 Garden Road Central Hong Kong S.A.R. Form 20-F x Form 40-F o o o Description]
[.FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif} .SmallFormData {color: blue; background-color: white; font-size: x-small; font-family: Times, serif} .FootnoteData {color: green; background-color: white; font-size: x-small; font-family: Times, serif} .FormText {font-size: x-small; font-family: arial, helvetica, sans-serif} .SmallFormText {font-size: xx-small; font-family: arial, helvetica, sans-serif} .FormTitle {font-size: medium; font-family: arial, helvetica, sans-serif; font-weight: bold} .FormName {font-size: large; font-family: arial, helvetica, sans-serif;]
[China Cord Blood Corporations Special Committee Appoints As previously announced, the Companys board of directors formed the Special Committee to review and evaluate the April 27, 2015 non-binding proposal from Golden Meditech Holdings Limited (Golden Meditech) to acquire all of the outstanding ordinary shares of the Company not already directly or indirectly owned by Golden Meditech in a going private] [FORM 6-K Commission Filing Number: 001-34541 CHINA CORD BLOOD CORPORATION 48th Floor, Bank of China Tower 1 Garden Road Central Hong Kong S.A.R. Form 20-F x Form 40-F o o o Description]
